Annual report pursuant to Section 13 and 15(d)

Notes Payable (Details Narrative)

v3.19.1
Notes Payable (Details Narrative)
12 Months Ended
Apr. 09, 2018
USD ($)
shares
Apr. 03, 2018
USD ($)
shares
Mar. 16, 2018
USD ($)
shares
Feb. 16, 2018
$ / shares
shares
Feb. 16, 2018
USD ($)
$ / shares
shares
Feb. 01, 2018
Aug. 23, 2017
USD ($)
Oct. 07, 2016
USD ($)
$ / shares
shares
Dec. 31, 2018
USD ($)
shares
Dec. 31, 2017
USD ($)
Integer
$ / shares
shares
Feb. 14, 2018
USD ($)
Jan. 22, 2018
USD ($)
Debt Instrument [Line Items]                        
Convertible note principal amount                     $ 55,000  
Fair value of warrants $ 247,360                      
Amortization of debt discount                 $ 528,929 $ 2,285,173    
Fair value of issuance of share   $ 70,000                    
Debt instrument conversion value                 4,353,988      
Gain on settlement                 2,136,860      
Issuance of share common stock | shares   25,669               11,503    
Warrant to purchase of common stock | shares 1,030,115                      
Debt instrument interest rate                     8.00%  
Repayment of debt         $ 688,238       55,000      
Repayment of debt principal amount         $ 545,000              
Aggregate of principal and interest converted into common stock                      
Interest expense, net                 $ 106,060 $ 946,131    
Series D Convertible Preferred Stock [Member]                        
Debt Instrument [Line Items]                        
Number of Series D Convertible Preferred Stock issued | shares       12,005 12,005       5,141 0    
Fair value of issuance of share         $ 12,005,000              
Debt instrument conversion value         $ 17,805,175              
Gain on settlement                 $ 5,800,175      
JMJ Promissory Note [Member]                        
Debt Instrument [Line Items]                        
Warrant exercise price, shares | shares                   100,001    
Aggregate borrowing value                   $ 3,500,000    
Number of warrants | Integer                   10    
Aggregate warrant exercise price                   $ 3,500,000    
Fair value of warrants                   147,569    
Amortization of debt discount                   2,610,568    
Original issue discount                   499,435    
Amortization expense                   2,133,865    
Accrued default penalty                   12,000,000    
Other Notes [Member]                        
Debt Instrument [Line Items]                        
Repayment of debt                 50,000      
Repayment of debt principal amount                 160,000      
Aggregate principal repayments                   4,815    
Other Notes [Member] | Lenders [Member]                        
Debt Instrument [Line Items]                        
Fair value of warrants                   $ 52,260    
Debt instrument interest rate                   12.00%    
Other notes                   $ 260,000    
Maximum equity investors or through debt financings notes mature value                   $ 5,000,000    
Warrant shares issued in connection with note issuances | shares                   15,600    
Warrant exercise price per share | $ / shares                   $ 35.00    
Warrant description                   The Company issued five-year warrants to purchase an aggregate of 15,600 shares of common stock at an exercise price equal to the lower of $35.00 per share or a price equal to a 20% discount to the price per share sold in any equity financing transaction within the next twelve months whereby the Company cumulatively receives at least $1,000,000.    
Other Notes Payable [Member]                        
Debt Instrument [Line Items]                        
Repayment of debt principal amount                 $ 50,000      
Public Offering [Member]                        
Debt Instrument [Line Items]                        
Issuance of share common stock | shares       4,353,000                
Warrant to purchase of common stock | shares       8,706,000 8,706,000              
Warrant exercise price per share | $ / shares       $ 4.25 $ 4.25              
JMJ [Member]                        
Debt Instrument [Line Items]                        
Fair value of warrants $ 35,313                      
Fair value of issuance of share     $ 205,881                  
Due to related party                       $ 250,000
Issuance of share common stock | shares     73,529                  
Warrant to purchase of common stock | shares 147,058                      
JMJ [Member] | Public Offering [Member]                        
Debt Instrument [Line Items]                        
Conversion of notes into common stock, description           On February 1, 2018, the Company and JMJ entered into a letter agreement whereby the parties agreed that, concurrent with the closing of the public offering, the Company will convert the JMJ Advance into units, with each unit consisting of one share of restricted common stock and a warrant to purchase one share of restricted common stock at an exercise price equal to the exercise price of the warrants sold as part of the public offering, at a price equal to 80% of the per unit price in the public offering.            
Farkas Group Inc. [Member] | Convertible Notes Payable [Member]                        
Debt Instrument [Line Items]                        
Convertible note principal amount                   $ 50,000    
Debt instrument interest rate                   15.00%    
Debt instrument convertible price per shares | $ / shares                   $ 35.00    
BLNK Holdings, LLC [Member]                        
Debt Instrument [Line Items]                        
Aggregate principal repayments                   $ 5,078    
BLNK Holdings, LLC [Member] | Convertible Notes Payable [Member]                        
Debt Instrument [Line Items]                        
Convertible note principal amount                   $ 207,645    
Debt instrument interest rate                   10.00%    
Securities and Purchase Agreement [Member] | JMJ Promissory Note [Member]                        
Debt Instrument [Line Items]                        
Fair value of obligation                   $ 1,680,000    
Securities and Purchase Agreement [Member] | JMJ [Member] | Public Offering [Member]                        
Debt Instrument [Line Items]                        
Conversion of notes into common stock, description               (a) 80% of the per share price of the common stock in the Company's contemplated public offering, (b) $35.00 per share, (c) 80% of the unit price in the public offering (if applicable), (d) the exercise price of any warrants issued in the public offering, or (e) the lowest conversion price, exercise price, or exchange price, of any security issued by the Company that is outstanding on October 13, 2016.        
Common stock price per shares | $ / shares               $ 35.00        
Securities and Purchase Agreement [Member] | JMJ [Member] | February 15, 2018 [Member]                        
Debt Instrument [Line Items]                        
Convertible note principal amount               $ 3,725,000        
Warrant term               5 years        
Warrant exercise price, shares | shares               100,001        
Promissory Note [Member] | JMJ Promissory Note [Member]                        
Debt Instrument [Line Items]                        
Aggregate borrowing value                   $ 3,725,000    
BLNK Conversion Agreement [Member]                        
Debt Instrument [Line Items]                        
Debt instrument, description                   On January 4, 2018, the parties agreed to extend the expiration date of the BLNK Conversion Agreement from December 29, 2017 to February 14, 2018.    
BLNK Conversion Agreement [Member] | BLNK Holdings, LLC [Member] | Public Offering [Member]                        
Debt Instrument [Line Items]                        
Conversion of notes into common stock, description             (i) the debt amount multiplied by a factor of 1.15 and (ii) then divided by 80% of the per share price of common stock sold in the public offering.          
Aggregate of principal and interest converted into common stock             $ 209,442